ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 18300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 18300; 2) Community: the network communities that were significantly associated with the response to NSC 18300; 3) Molecule: the relationships between components within communities and NSC 18300; 4) MDR: the compounds that were significantly associated with the NSC 18300.

NSC Compound Enrichment Correlation
NSC 704851 Null 0.00243861794188209 0.26426309
NSC 720641 8-chloro-3-(3,5-dimethoxyphenylamino)-7-methyl-1,2,4-triazol o[4,3-b][1,2,4]benzodithiazine-5,5-dioxide 0.00243861794188209 0.39221086
NSC 721554 Null 0.00243861794188209 -0.12777171
NSC 648365 Insulin-Methotrexate conjugate 0.00265989583551648 0.18962513
NSC 661960 Null 0.00265989583551648 0.36577364
NSC 662116 4H-Cyclopenta[c]thiophen-4-one, 6-amino-1,3-dibromo- 5,6-dihydro-, hydrochloride 0.00265989583551648 0.30716731
NSC 671169 Null 0.00265989583551648 0.090995814
NSC 676343 Null 0.00265989583551648 0.089999603
NSC 740387 1N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-[4-(3-{4-(3-(4-flu orophenyl)-3-oxo-(E)-1-propenyl]-2-methoxyphenoxy}propyl)hex ahydro-1-pyrazinyl]acetamide 0.00265989583551648 0.18559803
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.00265989583551648 0.27464929
Total:82  Current:5    [First] [Prev] [Next] [Last]